Authors: KROH UF DINGES GK LUKASEWITZ P STEINHAUSSER WU HOLL TJ LENNARTZ H

Citation: Uf. Kroh et al., ELIMINATION OF DRUGS BY THE NEW POLYAMIDE HEMOFILTER FH77H DURING VARIOUS IN-VITRO CONDITIONS, Blood purification, 16(1), 1998, pp. 49-56

Authors: KROH UF HOLL TJ STEINHUSSER W

Citation: Uf. Kroh et al., MANAGEMENT OF DRUG DOSING IN CONTINUOUS RENAL REPLACEMENT THERAPY, Seminars in dialysis, 9(2), 1996, pp. 161-165

Authors: KROH UF LENNARTZ H EDWARDS DJ STOECKEL K

Citation: Uf. Kroh et al., PHARMACOKINETICS OF CEFTRIAXONE IN PATIENTS UNDERGOING CONTINUOUS VENOVENOUS HEMOFILTRATION, Journal of clinical pharmacology, 36(12), 1996, pp. 1114-1119

Authors: DEHNE MG KROH UF

Citation: Mg. Dehne et Uf. Kroh, IMIPENEM CILASTIN DOSAGE DURING ACUTE-RENAL-FAILURE AND HEMOFILTRATION/, Intensive care medicine, 21(10), 1995, pp. 863-863